Androgens in cardiac fibrosis and other cardiovascular mechanisms

International Journal of Cardiology

Volumn 179, Issue , 2015, Pages 190-192

  Čulić, Viktor ^a,b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Arrhythmogenesis; Cardiovascular mechanisms; Exercise; Heart failure; Testosterone; Vasodilation

Indexed keywords

TESTOSTERONE; ANDROGEN; ANGIOTENSIN II; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARDIOVASCULAR FUNCTION; CORONARY ARTERY DILATATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; MUSCLE STRENGTH; NONHUMAN; PROGNOSIS; TESTOSTERONE BLOOD LEVEL; ANIMAL; CYTOLOGY; FIBROBLAST; HEART MUSCLE; MALE; PHYSIOLOGY;

ANDROGENS; ANGIOTENSIN II; ANIMALS; FIBROBLASTS; MALE; MYOCARDIUM; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84920694971     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.11.079     Document Type: Article

References (53)

1. C.C. Chung, R.C. Hsu, Y.H. Kao, J.P. Liou, and Y.J. Chen Androgen attenuates cardiac fibroblasts activations through modulations of transforming growth factor-β and angiotensin II signaling Int. J. Cardiol. 176 2014 386 393
2. S. Basaria, A.D. Coviello, and T.G. Travison Adverse events associated with testosterone administration N. Engl. J. Med. 363 2010 109 122
3. A. D'Andrea, P. Caso, and G. Salerno Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis Br. J. Sports Med. 41 2007 149 155
4. M. Toma, F.A. McAlister, and E.E. Coglianese Testosterone supplementation in heart failure: a meta-analysis Circ. Heart Fail. 5 2012 315 321
5. F. Iellamo, M. Volterrani, and G. Caminiti Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study J. Am. Coll. Cardiol. 56 2010 1310 1316
6. G. Caminiti, M. Volterrani, and F. Iellamo Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: a double-blind, placebo-controlled, randomized study J. Am. Coll. Cardiol. 54 2009 919 927
7. C.J. Malkin, P.J. Pugh, J.N. West, E.J. van Beek, T.H. Jones, and K.S. Channer Testosterone therapy in men with moderate severity heart failure: a double-blind placebo controlled trial Eur. Heart J. 27 2006 57 64
8. P.J. Pugh, R.D. Jones, J.N. West, T.H. Jones, and K.S. Channer Testosterone treatment for men with chronic heart failure Heart 90 2004 446 447
9. V. Čulić, and Ž. Bušić Severity of acute heart failure in men according to diabetes mellitus: the role of testosterone and renal dysfunction Int. J. Cardiol. 168 2013 5039 5041
10. E.A. Jankowska, B. Biel, and J. Majda Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival Circulation 114 2006 1829 1837
11. J. Arnlöv, M.J. Pencina, and S. Amin Endogenous sex hormones and cardiovascular disease incidence in men Ann. Intern. Med. 145 2006 176 184
12. G. Kabakci, A. Yildirir, I. Can, I. Unsal, and B. Erbas Relationship between endogenous sex hormones levels, lipoproteins, and coronary atherosclerosis in men undergoing coronary angiography Cardiology 92 1999 221 225
13. X. Hu, L. Rui, and T. Zhu Low testosterone level in middle-aged male patients with coronary artery disease Eur. J. Intern. Med. 22 2011 e133 e136
14. M. Akishita, M. Hashimoto, and Y. Ohike Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors Atherosclerosis 210 2010 232 236
15. G. Rosano, I. Sheiban, and R. Massaro Low testosterone levels are associated with coronary artery disease in male patients with angina Int J Impot Res 19 2007 176 182
16. S. Dobrzycki, W. Serwatka, and S. Nadlewski An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males J. Med. Invest. 50 2003 162 169
17. K.M. English, O. Mandour, R.P. Steeds, M.J. Diver, T.H. Jones, and K.S. Channer Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms Eur. Heart J. 21 2000 890 894
18. G. Corona, G. Rastrelli, L. Vignozzi, E. Mannucci, and M. Maggi Testosterone, cardiovascular disease and the metabolic syndrome Best Pract. Res. Clin. Endocrinol. Metab. 25 2011 337 353
19. C. Ohlsson, E. Barrett-Connor, and S. Bhasin High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (osteoporotic fractures in men) study in Sweden J. Am. Coll. Cardiol. 58 2011 1674 1682
20. G. Corona, M. Monami, and G. Rastrelli Type 2 diabetes mellitus and testosterone: a meta-analysis study Int. J. Androl. 34 6 Pt 1 2010 528 540
21. E.L. Ding, Y. Song, V.S. Malik, and S. Liu Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis JAMA 295 2006 1288 1299
22. L. Li, C.Y. Guo, and E.Z. Jia Testosterone is negatively associated with the severity of coronary atherosclerosis in men Asian J. Androl. 14 2012 875 878
23. A.B. Araujo, J.M. Dixon, E.A. Suarez, M.H. Murad, L.T. Guey, and G.A. Wittert Endogenous testosterone and mortality in men: a systemic review and meta-analysis J. Clin. Endocrinol. Metab. 96 2011 3007 3019
24. C.J. Malkin, P.J. Pugh, P.D. Morris, S. Asif, T.H. Jones, and K.S. Channer Low serum testosterone and increased mortality in men with coronary heart disease Heart 96 2010 1821 1825
25. S.M. Kang, Y. Jang, Kim Ji, N. Chung, S.Y. Cho, J.S. Chae, and J.H. Lee Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease Am. J. Cardiol. 89 2002 862 864
26. P. Tep-areenan, D.A. Kendall, and M.D. Randall Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is predominantly via potassium channels Br. J. Pharmacol. 135 2002 735 740
27. P.J. Ong, G. Patrizi, W.C. Chong, C.M. Webb, C.S. Hayward, and P. Collins Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease Am. J. Cardiol. 85 2000 269 272
28. K.M. English, R.D. Jones, and T.H. Jones Testosterone acts as a coronary vasodilator by a calcium antagonistic action J. Endocrinol. Invest. 25 2002 455 458
29. K.M. English, R.D. Jones, T.H. Jones, A.H. Morice, and K.S. Channer Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries Horm. Metab. Res. 33 2001 1 8
30. C.M. Webb, J.G. McNeill, C.S. Hayward, D. de Zeigler, and P. Collins Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease Circulation 100 1999 1690 1696
31. R.D. Jones, K.M. English, P.J. Pugh, A.H. Morice, T.H. Jones, and K.S. Channer The pulmonary vasodilatory action of testosterone - evidence of a calcium antagonistic action J. Cardiovasc. Pharmacol. 39 2002 814 823
32. E.K. O'Connor, J.R. Ivey, and D.K. Bowles Differential effects of androgens on coronary blood flow regulation and arteriolar diameter in intact and castrated swine Biol. Sex Differ. 3 2012 10
33. E. Cairrão, A.J. Santos-Silva, and I. Verde PKG is involved in testosterone-induced vasorelaxation of human umbilical artery Eur. J. Pharmacol. 640 2010 94 101
34. 2 + channels Biochem. Biophys. Res. Commun. 318 2004 503 506
35. T.M. Chou, K. Sudhir, and S.J. Hutchison Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo Circulation 94 1996 2614 2619
36. V. Čulić, and Ž. Bušić Testosterone levels and heart failure in obese and non-obese men Int. J. Cardiol. 176 2014 1163 1166
37. E.A. Jankowska, G. Filippatos, and B. Ponikowska Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure J. Card. Fail. 15 2009 442 450
38. M. Czesla, G. Mehlhorn, D. Fritzsche, and G. Asmussen Cardiomyoplasty - improvement of muscle fiber type transformation by an anabolic steroid (metenolone) J. Mol. Cell. Cardiol. 29 1997 2989 2996
39. J.L. Vingren, W.J. Kraemer, N.A. Ratamess, J.M. Anderson, J.S. Volek, and C.M. Maresh Testosterone physiology in resistance exercise and training: the up-stream regulatory elements Sports Med. 40 2010 1037 1053
40. V.N. Hawkins, K. Foster-Schubert, and J. Chubak Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial Med. Sci. Sports Exerc. 40 2008 223 233
41. G. Caminiti, F. Iellamo, and V. Manzi Anabolic hormonal response to different exercise training intensities in men with chronic heart failure Int. J. Cardiol. 176 2014 1433 1434
42. A.C. Hackney, K.P. Hosick, A. Myer, D.A. Rubin, and C.L. Battaglini Testosterone responses to intensive interval versus steady-state endurance exercise J. Endocrinol. Invest. 35 2012 947 950
43. C. van Noord, M. Dörr, and M.C. Sturkenboom The association of serum testosterone levels and ventricular repolarization Eur. J. Epidemiol. 25 2010 21 28
44. C.J. Malkin, P.D. Morris, P.J. Pugh, K.M. English, and K.S. Channer Effect of testosterone therapy on QT dispersion in men with heart failure Am. J. Cardiol. 92 2003 1241 1243
45. A.S. Maior, P. Menezes, and R.C. Pedrosa Abnormal cardiac repolarization in anabolic androgenic steroid users carrying out submaximal exercise testing Clin. Exp. Pharmacol. Physiol. 37 2010 1129 1133
46. N. Sculthorpe, F. Grace, P. Jones, and B. Davies Evidence of altered cardiac electrophysiology following prolonged androgenic anabolic steroid use Cardiovasc. Toxicol. 10 2010 239 243
47. D.H. Lau, M.K. Stiles, B. John, Shashidhar, G.D. Young, and P. Sanders Atrial fibrillation and anabolic steroid abuse Int. J. Cardiol. 117 2007 e86 e87
48. M.L. Sullivan, C.M. Martinez, and E.J. Gallagher Atrial fibrillation and anabolic steroids J. Emerg. Med. 17 1999 851 857
49. J.W. Magnani, C.B. Moser, and J.M. Murabito Association of sex hormones, aging and atrial fibrillation in men: the Framingham heart study Circ. Arrhythm. Electrophysiol. 7 2014 307 312
50. T. Tsuneda, T. Yamashita, and T. Kato Deficiency of testosterone associates with the substrate of atrial fibrillation in the rat model J. Cardiovasc. Electrophysiol. 20 2009 1055 1060
51. O.M. Calof, A.B. Singh, and M.L. Lee Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials J. Gerontol. A Biol. Sci. Med. Sci. 60 2005 1451 1457
52. W.C. Tsai, T.I. Lee, and Y.C. Chen Testosterone replacement increases aged pulmonary vein and left atrium arrhythmogenesis with enhanced adrenergic activity Int. J. Cardiol. 176 2014 110 118
53. M.A. Cavasin, S.S. Sankey, A.L. Yu, S. Menon, and X.P. Yang Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction Am. J. Physiol. Heart Circ. Physiol. 284 2003 H1560 H1569